ArticleAnnals of surgical oncology2026

Real-World Adoption of Adjuvant Immune Checkpoint Inhibition in Stage IIB/IIC Melanoma Following FDA Approval.

James W Jakub et al.PubMed ↗Publisher ↗

No numbers read from the abstract.